|
PAPD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.775400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.090300E-02 |
| Normal-vs-Stage2 |
4.038700E-03 |
| Normal-vs-Stage3 |
2.650800E-01 |
| Normal-vs-Stage4 |
1.224610E-01 |
| Stage1-vs-Stage2 |
1.608440E-02 |
| Stage1-vs-Stage3 |
7.228600E-01 |
| Stage1-vs-Stage4 |
3.841600E-01 |
| Stage2-vs-Stage3 |
2.466000E-01 |
| Stage2-vs-Stage4 |
4.471400E-01 |
| Stage3-vs-Stage4 |
7.483600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.240390E-02 |
| Normal-vs-AfricanAmerican |
1.497850E-02 |
| Normal-vs-Asian |
2.170400E-01 |
| Caucasian-vs-AfricanAmerican |
3.230600E-01 |
| Caucasian-vs-Asian |
3.033800E-01 |
| AfricanAmerican-vs-Asian |
3.755800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.684600E-03 |
| Normal-vs-Female |
1.195190E-03 |
| Male-vs-Female |
1.364230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.115600E-02 |
| Normal-vs-Extreme_Weight |
1.994850E-01 |
| Normal-vs-Obese |
2.039800E-02 |
| Normal-vs-Extreme_Obese |
4.369000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.992600E-01 |
| Normal_Weight-vs-Obese |
8.866600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.233000E-01 |
| Extreme_Weight-vs-Obese |
2.327000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.800000E-01 |
| Obese-vs-Extreme_Obese |
8.526000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.813900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.182600E-04 |
| Normal-vs-Age(61-80Yrs) |
3.371900E-02 |
| Normal-vs-Age(81-100Yrs) |
8.734200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.673400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.621600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.412400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.452210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.500010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.700800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.876600E-03 |
| Normal-VS-Type2 PRCC |
2.863500E-02 |
| Normal-VS-KIRP CIMP |
6.296800E-01 |
| Normal-VS-Unclassified PRCC |
1.955610E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.446200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.147360E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.477000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.274200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.600800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.043790E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.273900E-02 |
| Normal-vs-N1 |
1.193220E-01 |
| Normal-vs-N2 |
4.898400E-01 |
| N0-vs-N1 |
8.795800E-01 |
| N0-vs-N2 |
3.982000E-01 |
| N1-vs-N2 |
3.268600E-01 |
|
|
